Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N047A.
Perez DG, Suman VJ, Fitch TR, Amatruda T 3rd, Morton RF, Jilani SZ, Constantinou CL, Egner JR, Kottschade LA, Markovic SN. Perez DG, et al. Among authors: jilani sz. Cancer. 2009 Jan 1;115(1):119-27. doi: 10.1002/cncr.23987. Cancer. 2009. PMID: 19090009 Free PMC article. Clinical Trial.
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105).
Mezzanotte-Sharpe J, ONeill A, Mayer IA, Arteaga CL, Yang XJ, Wagner LI, Cella D, Meropol NJ, Alpaugh RK, Saphner TJ, Swaney RE, Hoelzer KL, Gradishar WJ, Abramson VG, Sundaram PK, Jilani SZ, Perez EA, Lin NU, Jahanzeb M, Wolff AC, Sledge GW, Reid SA. Mezzanotte-Sharpe J, et al. Among authors: jilani sz. Breast Cancer Res Treat. 2024 Sep;207(2):275-282. doi: 10.1007/s10549-024-07417-4. Epub 2024 Jul 5. Breast Cancer Res Treat. 2024. PMID: 38967884 Free PMC article. Clinical Trial.
A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105).
Mezzanotte-Sharpe J, ONeill A, Mayer IA, Arteaga CL, Yang XJ, Wagner LI, Cella D, Meropol NJ, Alpaugh RK, Saphner TJ, Swaney RE, Hoelzer KL, Gradishar WJ, Abramson VG, Sundaram PK, Jilani SZ, Perez EA, Lin NU, Jahanzeb M, Wolff AC, Sledge GW, Reid SA. Mezzanotte-Sharpe J, et al. Among authors: jilani sz. Res Sq [Preprint]. 2024 Apr 29:rs.3.rs-4295044. doi: 10.21203/rs.3.rs-4295044/v1. Res Sq. 2024. Update in: Breast Cancer Res Treat. 2024 Sep;207(2):275-282. doi: 10.1007/s10549-024-07417-4 PMID: 38746356 Free PMC article. Updated. Preprint.
Progress and limitations in reactive oxygen species quantitation.
Spanolios EM, Lewis RE, Caldwell RN, Jilani SZ, Haynes CL. Spanolios EM, et al. Among authors: jilani sz. Chem Commun (Camb). 2024 Oct 24;60(86):12487-12501. doi: 10.1039/d4cc03578j. Chem Commun (Camb). 2024. PMID: 39373601 Review.
A Diverse View of Science to Catalyse Change.
Urbina-Blanco CA, Jilani SZ, Speight IR, Bojdys MJ, Friščić T, Stoddart JF, Nelson TL, Mack J, Robinson RAS, Waddell EA, Lutkenhaus JL, Godfrey M, Abboud MI, Aderinto SO, Aderohunmu D, Bibič L, Borges J, Dong VM, Ferrins L, Fung FM, John T, Lim FPL, Masters SL, Mambwe D, Thordarson P, Titirici MM, Tormet-González GD, Unterlass MM, Wadle A, Yam VW, Yang YW. Urbina-Blanco CA, et al. Among authors: jilani sz. Angew Chem Int Ed Engl. 2020 Oct 12;59(42):18306-18310. doi: 10.1002/anie.202009834. Epub 2020 Aug 17. Angew Chem Int Ed Engl. 2020. PMID: 33448562 Free PMC article. Review.
A diverse view of science to catalyse change.
Urbina-Blanco CA, Jilani SZ, Speight IR, Bojdys MJ, Friščić T, Stoddart JF, Nelson TL, Mack J, Robinson RAS, Waddell EA, Lutkenhaus JL, Godfrey M, Abboud MI, Aderinto SO, Aderohunmu D, Bibič L, Borges J, Dong VM, Ferrins L, Fung FM, John T, Lim FPL, Masters SL, Mambwe D, Thordarson P, Titirici MM, Tormet-González GD, Unterlass MM, Wadle A, Yam VW, Yang YW. Urbina-Blanco CA, et al. Among authors: jilani sz. Nat Chem. 2020 Sep;12(9):773-776. doi: 10.1038/s41557-020-0529-x. Nat Chem. 2020. PMID: 32807887 No abstract available.
A Diverse View of Science to Catalyse Change.
Urbina-Blanco CA, Jilani SZ, Speight IR, Bojdys MJ, Friščić T, Stoddart JF, Nelson TL, Mack J, Robinson RAS, Waddell EA, Lutkenhaus JL, Godfrey M, Abboud MI, Aderinto SO, Aderohunmu D, Bibič L, Borges J, Dong VM, Ferrins L, Fung FM, John T, Lim FPL, Masters SL, Mambwe D, Thordarson P, Titirici MM, Tormet-González GD, Unterlass MM, Wadle A, Yam VW, Yang YW. Urbina-Blanco CA, et al. Among authors: jilani sz. J Am Chem Soc. 2020 Aug 26;142(34):14393-14396. doi: 10.1021/jacs.0c07877. Epub 2020 Aug 17. J Am Chem Soc. 2020. PMID: 32803980 No abstract available.
12 results